Hence, differential NRP-1 processing—i.e., the generation of soluble and intracellular fragments with distinct signalling characteristics via alternative splicing and proteolytic degradation, reflected by soluble NRP-1 plasma levels—might link to the individual MetS phenotype represented by individual cardiac, vascular and metabolic risk components. The gene discussed is NRP1; the disease is metabolic syndrome.